Glioblastoma Stem Cells Respond to Differentiation Cues but Fail to Undergo Commitment and Terminal Cell-Cycle Arrest
暂无分享,去创建一个
Andrew E. Teschendorff | Stephan Beck | Harry Bulstrode | Paul Bertone | Stefan H. Stricker | Andrew Feber | Thomas E. Bartlett | Helena Carén | Paul Bertone | A. Teschendorff | S. Beck | S. Stricker | G. Wilson | A. Feber | H. Carén | S. Pollard | H. Bulstrode | Sladjana Gagrica | E. Johnstone | Ewan Johnstone | Gareth Wilson | Steven M. Pollard | Sladjana Gagrica
[1] U. Schüller,et al. ALDH1A1 is a Marker of Astrocytic Differentiation during Brain Development and Correlates with Better Survival in Glioblastoma Patients , 2012, Brain pathology.
[2] S. Sell,et al. Stem cell origin of cancer and differentiation therapy. , 2004, Critical reviews in oncology/hematology.
[3] Paul Bertone,et al. Digital transcriptome profiling of normal and glioblastoma-derived neural stem cells identifies genes associated with patient survival , 2012, Genome Medicine.
[4] Howard Y. Chang,et al. Transposition of native chromatin for fast and sensitive epigenomic profiling of open chromatin, DNA-binding proteins and nucleosome position , 2013, Nature Methods.
[5] S. Pollard. In vitro expansion of fetal neural progenitors as adherent cell lines. , 2013, Methods in molecular biology.
[6] Rafael A Irizarry,et al. Exploration, normalization, and summaries of high density oligonucleotide array probe level data. , 2003, Biostatistics.
[7] Su-Chun Zhang. Defining glial cells during CNS development , 2001, Nature Reviews Neuroscience.
[8] Daniel A. Lim,et al. Subventricular Zone Astrocytes Are Neural Stem Cells in the Adult Mammalian Brain , 1999, Cell.
[9] R. Rosenfeld. Nature , 2009, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.
[10] G. Broggi,et al. Bone morphogenetic proteins inhibit the tumorigenic potential of human brain tumour-initiating cells , 2006, Nature.
[11] Simon Kasif,et al. Reconstructing and Reprogramming the Tumor-Propagating Potential of Glioblastoma Stem-like Cells , 2014, Cell.
[12] S. Weiss,et al. Transcription factors FOXG1 and Groucho/TLE promote glioblastoma growth , 2013, Nature Communications.
[13] Kiran C. Bobba,et al. Discovery of Novel Recurrent Mutations in Childhood Early T-Cell Precursor Acute Lymphoblastic Leukemia by Whole Genome Sequencing - a Report From the St Jude Children's Research Hospital - Washington University Pediatric Cancer Genome Project , 2011 .
[14] Irving L. Weissman,et al. A comprehensive methylome map of lineage commitment from hematopoietic progenitors , 2010, Nature.
[15] J. Fawcett,et al. An efficient method for derivation and propagation of glioblastoma cell lines that conserves the molecular profile of their original tumours , 2009, Journal of Neuroscience Methods.
[16] Andrew E. Teschendorff,et al. ChAMP: 450k Chip Analysis Methylation Pipeline , 2014, Bioinform..
[17] Colin N. Dewey,et al. RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome , 2011, BMC Bioinformatics.
[18] J. L. Mateo,et al. Epigenomic enhancer annotation reveals a key role for NFIX in neural stem cell quiescence , 2013, Genes & development.
[19] D. Haussler,et al. The Somatic Genomic Landscape of Glioblastoma , 2013, Cell.
[20] Zev A. Binder,et al. The Genetic Landscape of the Childhood Cancer Medulloblastoma , 2011, Science.
[21] S. Beck,et al. The good, the bad and the ugly: Epigenetic mechanisms in glioblastoma , 2013, Molecular aspects of medicine.
[22] David T. W. Jones,et al. Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma , 2012, Nature.
[23] R. Henkelman,et al. Identification of human brain tumour initiating cells , 2004, Nature.
[24] A. Kriegstein,et al. Developmental genetics of vertebrate glial–cell specification , 2010, Nature.
[25] Paul Bertone,et al. Widespread resetting of DNA methylation in glioblastoma-initiating cells suppresses malignant cellular behavior in a lineage-dependent manner. , 2013, Genes & development.
[26] Mark Bernstein,et al. Glioma stem cell lines expanded in adherent culture have tumor-specific phenotypes and are suitable for chemical and genetic screens. , 2009, Cell stem cell.
[27] U. Lendahl,et al. Expression of the class VI intermediate filament nestin in human central nervous system tumors. , 1992, Cancer research.
[28] W. Huber,et al. which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. MAnorm: a robust model for quantitative comparison of ChIP-Seq data sets , 2011 .
[29] M. Bonaguidi,et al. LIF and BMP signaling generate separate and discrete types of GFAP-expressing cells , 2005, Development.
[30] Yuri Kotliarov,et al. Epigenetic-mediated dysfunction of the bone morphogenetic protein pathway inhibits differentiation of glioblastoma-initiating cells. , 2008, Cancer cell.
[31] Patrick J. Paddison,et al. A High-Content Small Molecule Screen Identifies Sensitivity of Glioblastoma Stem Cells to Inhibition of Polo-Like Kinase 1 , 2013, PloS one.
[32] Gary D Bader,et al. Epigenomic alterations define lethal CIMP-positive ependymomas of infancy , 2014, Nature.
[33] G. Parkin,et al. Long-term tripotent differentiation capacity of human neural stem (NS) cells in adherent culture , 2008, Molecular and Cellular Neuroscience.
[34] Li Ding,et al. Somatic Histone H3 Alterations in Paediatric Diffuse Intrinsic Pontine Gliomas and Non-Brainstem Glioblastomas , 2012, Nature Genetics.
[35] S. Morrison,et al. Heterogeneity in Cancer: Cancer Stem Cells versus Clonal Evolution , 2009, Cell.